Platelet-Rich Plasma for Knee Osteoarthritis and Patient-Reported Outcomes: A Large Retrospective Analysis
Jonathan P. Coss, Kenar Z. Gelman, Ryan Lingor, Kaylre Greaves, Courtney Melone, Michael Parides, Brian C. HalpernBackground:
Platelet-rich plasma (PRP) is used increasingly to treat knee osteoarthritis (OA). This study aimed to describe PRP use for knee OA and identify patient- and treatment-specific factors associated with clinical outcomes.
Hypothesis:
Patients with knee OA undergoing intra-articular PRP injections would demonstrate improvement in pain, function, and symptoms over time, with outcomes varying by patient and treatment characteristics.
Study Design:
Retrospective cohort study.
Level of Evidence:
Level 3.
Methods:
A total of 743 patients with knee OA were treated with intra-articular PRP injections. Outcomes were assessed using the Numeric Rating Scale (NRS, 0-100, higher scores indicating greater pain) and the Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS-JR). Change in patient-reported outcome measure (PROM) scores from baseline and achievement of patient acceptable symptom state (PASS) were measured. Repeated-measures mixed models evaluated outcomes at baseline, 6 months, and 1 year using an all-response analysis (391 patients for Pain NRS; 400 for KOOS-JR).
Results:
PRP injections were associated with improvement in pain, function, and symptom state. Pain NRS improved from 39.2 at baseline to 27.2 at 6 months and 22.4 at 1 year (both
Conclusion:
Intra-articular PRP injections were associated with improvements in pain, function, and symptoms in patients with knee OA. Differences between complete-case and all-response analyses suggest that follow-up patterns may influence estimated treatment response.
Clinical Relevance:
These findings describe patient-reported outcomes after intra-articular PRP injection for knee OA. Because this study lacked a control group, findings should not be interpreted as evidence that PRP caused the observed improvements.